Cargando…
Targeting the reversible drug-tolerant state: aurora kinase A, is that the final answer?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797747/ https://www.ncbi.nlm.nih.gov/pubmed/35117132 http://dx.doi.org/10.21037/tcr.2019.05.21 |
| _version_ | 1784641627031076864 |
|---|---|
| author | Suda, Kenichi |
| author_facet | Suda, Kenichi |
| author_sort | Suda, Kenichi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8797747 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87977472022-02-02 Targeting the reversible drug-tolerant state: aurora kinase A, is that the final answer? Suda, Kenichi Transl Cancer Res Editorial Commentary AME Publishing Company 2019-12 /pmc/articles/PMC8797747/ /pubmed/35117132 http://dx.doi.org/10.21037/tcr.2019.05.21 Text en 2019 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. |
| spellingShingle | Editorial Commentary Suda, Kenichi Targeting the reversible drug-tolerant state: aurora kinase A, is that the final answer? |
| title | Targeting the reversible drug-tolerant state: aurora kinase A, is that the final answer? |
| title_full | Targeting the reversible drug-tolerant state: aurora kinase A, is that the final answer? |
| title_fullStr | Targeting the reversible drug-tolerant state: aurora kinase A, is that the final answer? |
| title_full_unstemmed | Targeting the reversible drug-tolerant state: aurora kinase A, is that the final answer? |
| title_short | Targeting the reversible drug-tolerant state: aurora kinase A, is that the final answer? |
| title_sort | targeting the reversible drug-tolerant state: aurora kinase a, is that the final answer? |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797747/ https://www.ncbi.nlm.nih.gov/pubmed/35117132 http://dx.doi.org/10.21037/tcr.2019.05.21 |
| work_keys_str_mv | AT sudakenichi targetingthereversibledrugtolerantstateaurorakinaseaisthatthefinalanswer |